BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med. 2007;24:137-144. [PMID: 17257275 DOI: 10.1111/j.1464-5491.2007.02043.x] [Cited by in Crossref: 247] [Cited by in F6Publishing: 265] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Washirasaksiri C, Srivanichakorn W, Borrisut N, Sitasuwan T, Tinmanee R, Kositamongkol C, Ariyakunaphan P, Auesomwang C, Sayabovorn N, Chaisathaphol T, Phisalprapa P. Fasting plasma glucose and HbA1c levels predict the risk of type 2 diabetes and diabetic retinopathy in a Thai high-risk population with prediabetes. Front Pharmacol 2022;13:950225. [DOI: 10.3389/fphar.2022.950225] [Reference Citation Analysis]
2 Mittal M, Jethwani P, Naik D, Garg MK. Non-medicalization of medical science: Rationalization for future. World J Methodol 2022; 12(5): 402-413 [DOI: 10.5662/wjm.v12.i5.402] [Reference Citation Analysis]
3 Buysschaert M, Bergman M, Valensi P. 1-h post-load plasma glucose for detecting early stages of prediabetes. Diabetes & Metabolism 2022. [DOI: 10.1016/j.diabet.2022.101395] [Reference Citation Analysis]
4 Lee C, Han KD, Yoo J, Park K, Oh SY. The relationship between glycemic status and the risk of third, fourth, and sixth cranial nerve palsy: a nationwide population-based study (2009-2018).. [DOI: 10.21203/rs.3.rs-1860127/v1] [Reference Citation Analysis]
5 Hakim N. Weight distribution and the risk of type 2 diabetes among middle- to high-income women in Saudi Arabia: A cross-sectional study. Obesity Medicine 2022;33:100423. [DOI: 10.1016/j.obmed.2022.100423] [Reference Citation Analysis]
6 Gottwald-Hostalek U, Gwilt M. Vascular complications in prediabetes and type 2 diabetes: a continuous process arising from a common pathology. Curr Med Res Opin 2022;:1-30. [PMID: 35833523 DOI: 10.1080/03007995.2022.2101805] [Reference Citation Analysis]
7 Kirthi V, Nderitu P, Alam U, Evans JR, Nevitt S, Malik RA, Hopkins D, Jackson TL. The prevalence of retinopathy in prediabetes: A systematic review. Survey of Ophthalmology 2022. [DOI: 10.1016/j.survophthal.2022.04.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Kirthi V, Zuckerman BP, Alam U, Bunce C, Hopkins D, Jackson TL. ASSOCIATIONS BETWEEN DYSGLYCEMIA, RETINAL NEURODEGENERATION, AND MICROALBUMINURIA IN PREDIABETES AND TYPE 2 DIABETES. Retina 2022;42:442-9. [PMID: 35188489 DOI: 10.1097/IAE.0000000000003337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chen J, Wan Y, Su J, Zhu Z, Pan E, Shen C, Wen J, Wang K, Yu H, Qin Y, Cui L, Zhou J, Wu M. Association of Generalized and Abdominal Obesity with Diabetic Retinopathy in Chinese Type 2 Diabetic Patients. Acta Diabetol 2022;59:359-67. [PMID: 34713323 DOI: 10.1007/s00592-021-01806-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Verma A, Jha A, Alagorie AR, Sharma R. Association of anthropometric parameters as a risk factor for development of diabetic retinopathy in patients with diabetes mellitus. Eye. [DOI: 10.1038/s41433-022-01934-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Faura G, Boix-Lemonche G, Holmeide AK, Verkauskiene R, Volke V, Sokolovska J, Petrovski G. Colorimetric and Electrochemical Screening for Early Detection of Diabetes Mellitus and Diabetic Retinopathy-Application of Sensor Arrays and Machine Learning. Sensors (Basel) 2022;22:718. [PMID: 35161465 DOI: 10.3390/s22030718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Seo E, Lee Y, Mun E, Kim DH, Jeong Y, Lee J, Jeong J, Lee W. The effect of long working hours on developing type 2 diabetes in adults with prediabetes: The Kangbuk Samsung Cohort Study. Ann Occup Environ Med 2022;34:e4. [DOI: 10.35371/aoem.2022.34.e4] [Reference Citation Analysis]
13 Rajalakshmi R, Umasankari G, Sivaprasad S, Venkatesan U, Kumpatla S, Shanthirani CS, Viswanathan V, Mohan V. Prevalence and risk factors for diabetic retinopathy in prediabetes in Asian Indians. Journal of Diabetes and its Complications 2022. [DOI: 10.1016/j.jdiacomp.2022.108131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Jayanama K, Phuphuakrat A, Pongchaikul P, Prombutara P, Nimitphong H, Reutrakul S, Sungkanuparph S. Association between gut microbiota and prediabetes in people living with HIV. Current Research in Microbial Sciences 2022;3:100143. [DOI: 10.1016/j.crmicr.2022.100143] [Reference Citation Analysis]
15 Kohlenberg J, Vella A. “Is Prediabetes a Risk Factor or Is It a Disease?”. Clinical Dilemmas in Diabetes 2021. [DOI: 10.1002/9781119603207.ch1] [Reference Citation Analysis]
16 Multani EK, Bajwa D, Multani PK, Nobakht E, Raj D, Paul RS, Paul RS. EYE DISEASE IN KIDNEY TRANSPLANTATION: CLINICAL CHALLENGES IN A UNIQUE PATIENT POPULATION. Surv Ophthalmol 2021:S0039-6257(21)00226-5. [PMID: 34954092 DOI: 10.1016/j.survophthal.2021.12.007] [Reference Citation Analysis]
17 Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health 2021;42:59-77. [PMID: 33355476 DOI: 10.1146/annurev-publhealth-090419-102644] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
18 Guha MK. PREDIABETES – RISKS AND APPROACH FOR MANAGEMENT. PIJR 2021. [DOI: 10.36106/paripex/3500371] [Reference Citation Analysis]
19 Utzschneider KM. Reduced β-cell function and risk of retinopathy: What's the connection? J Diabetes Complications 2022;36:108045. [PMID: 34802901 DOI: 10.1016/j.jdiacomp.2021.108045] [Reference Citation Analysis]
20 Roy S, Demmer RT. Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes. Transl Res 2021:S1931-5244(21)00265-6. [PMID: 34763125 DOI: 10.1016/j.trsl.2021.11.002] [Reference Citation Analysis]
21 Bradley SA, Varghese FM, Menon B, Mehndiratta MM, Bhaskar SMM. Stroke in Patients with Diabetes: Is It Time to Expand Public Health Priority to Encompass High-Risk Patients with Increased Insulin Resistance? EMJ Diabet 2021. [DOI: 10.33590/emjdiabet/21-00171] [Reference Citation Analysis]
22 Marcondes FO, Cheng D, Alegria M, Haas JS. Are racial/ethnic minorities recently diagnosed with diabetes less likely than white individuals to receive guideline-directed diabetes preventive care? BMC Health Serv Res 2021;21:1150. [PMID: 34689778 DOI: 10.1186/s12913-021-07146-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Shah BR, Feig DS, Herer E, Hladunewich MA, Kiss A, Kohly RP, Lipscombe LL, Yip PM, Cherney DZ. Increased risk for microvascular complications among women with gestational diabetes in the third trimester. Diabetes Res Clin Pract 2021;180:109068. [PMID: 34563584 DOI: 10.1016/j.diabres.2021.109068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Yadav R, Jain N, Raizada N, Jhamb R, Rohatgi J, Madhu SV. Prevalence of diabetes related vascular complications in subjects with normal glucose tolerance, prediabetes, newly detected diabetes and known diabetes. Diabetes Metab Syndr 2021;15:102226. [PMID: 34303917 DOI: 10.1016/j.dsx.2021.102226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Emanuelsson F, Benn M. LDL-Cholesterol versus Glucose in Microvascular and Macrovascular Disease. Clin Chem 2021;67:167-82. [PMID: 33221847 DOI: 10.1093/clinchem/hvaa242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Palladino R, Tabak AG, Khunti K, Valabhji J, Majeed A, Millett C, Vamos EP. Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes. BMJ Open Diabetes Res Care 2020;8:e001061. [PMID: 32332069 DOI: 10.1136/bmjdrc-2019-001061] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 25.0] [Reference Citation Analysis]
27 Alvarez-Canales MFL, Salazar-López SS, Farfán-Vázquez D, Martínez-López YE, González-Mena JN, Jiménez-Ceja LM, Vargas-Ortiz K, Evia-Viscarra ML, Montes de Oca-Loyola ML, Folli F, Aguilar-García A, Guardado-Mendoza R. Effect of linagliptin on glucose metabolism and pancreatic beta cell function in patients with persistent prediabetes after metformin and lifestyle. Sci Rep 2021;11:8750. [PMID: 33888772 DOI: 10.1038/s41598-021-88108-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Tsilingiris D, Vallianou NG, Dalamaga M. Prediabetes screening: Questionable benefits in the golden years. Metabol Open 2021;10:100091. [PMID: 33912821 DOI: 10.1016/j.metop.2021.100091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Arredouani A. Greater and More Focused Measures Are Needed to Tackle Diabetes and Obesity Epidemics in the Nations of the Gulf Cooperation Council. Int J Endocrinol 2021;2021:6661346. [PMID: 33833799 DOI: 10.1155/2021/6661346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ji L, Pranoto A, Andag-Silva A, Deerochanawong C, Van Phuoc D, Tan KCB, Tan K, Sung-Rae K, Mohamed MB, Shah P, Dang TH. Retracted: Western pacific consensus proposals for management of prediabetes. Int J Clin Pract 2021;:e14019. [PMID: 33480067 DOI: 10.1111/ijcp.14019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Gupta P, Lamoureux EL, Sabanayagam C, Tham YC, Tan G, Cheng CY, Wong TY, Cheung N. Six-year incidence and systemic associations of retinopathy in a multi-ethnic Asian population without diabetes. Br J Ophthalmol 2021:bjophthalmol-2020-318126. [PMID: 33468492 DOI: 10.1136/bjophthalmol-2020-318126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Gale MJ, Scruggs BA, Flaxel CJ. Diabetic eye disease: A review of screening and management recommendations. Clin Experiment Ophthalmol 2021;49:128-45. [DOI: 10.1111/ceo.13894] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
33 Lawal Y, Bello F, Kaoje YS. Prediabetes Deserves More Attention: A Review. Clin Diabetes 2020;38:328-38. [PMID: 33132502 DOI: 10.2337/cd19-0101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Baranowska-Jurkun A, Matuszewski W, Bandurska-Stankiewicz E. Chronic Microvascular Complications in Prediabetic States-An Overview. J Clin Med 2020;9:E3289. [PMID: 33066307 DOI: 10.3390/jcm9103289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
35 Chande PK, Raman R, John P, Srinivasan S. Contrast-Sensitivity Function and Photo Stress-Recovery Time in Prediabetes. Clin Optom (Auckl) 2020;12:151-5. [PMID: 32982530 DOI: 10.2147/OPTO.S259397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Nyenwe E, James D, Wan J, Dagogo-Jack S. Glycemic Response to Oral Dexamethasone Predicts Incident Prediabetes in Normoglycemic Subjects With Parental Diabetes. J Endocr Soc 2020;4:bvaa137. [PMID: 33134765 DOI: 10.1210/jendso/bvaa137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Rendell M. Pharmacotherapeutic options for prediabetes. Expert Opin Pharmacother 2021;22:45-54. [PMID: 32892663 DOI: 10.1080/14656566.2020.1817381] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Miravet-jiménez S, Pérez-unanua M, Alonso-fernández M, Escobar-lavado F, González-mohino Loro B, Piera-carbonell A. Manejo de la diabetes mellitus tipo 2 en adolescentes y adultos jóvenes en atención primaria. Medicina de Familia SEMERGEN 2020;46:415-24. [DOI: 10.1016/j.semerg.2019.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Ojo OS, Egunjobi AO, Fatusin AJ, Fatusin BB, Ojo OO, Ololade FA, Eruzegbua PA, Afolabi OA, Adesokan AA. Magnitude of missed opportunities for prediabetes screening among non-diabetic adults attending the family practice clinic in Western Nigeria: Implication for diabetes prevention. S Afr Fam Pract (2004) 2020;62:e1-e10. [PMID: 32896139 DOI: 10.4102/safp.v62i1.5082] [Reference Citation Analysis]
40 Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C, Zhang W, Zhang H, Xia F, Wang N, Lu Y. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol 2020;19:118. [PMID: 32736628 DOI: 10.1186/s12933-020-01095-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 23.0] [Reference Citation Analysis]
41 Liu J, Xing X, Wu X, Li X, Yao S, Ren Z, Zeng H, Wu S. Reduced Circulating Endothelial Progenitor Cells and Downregulated GTCPH I Pathway Related to Endothelial Dysfunction in Premenopausal Women with Isolated Impaired Glucose Tolerance. Cardiol Res Pract 2020;2020:1278465. [PMID: 32411442 DOI: 10.1155/2020/1278465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Amer OE, Sabico S, Alfawaz HA, Aljohani N, Hussain SD, Alnaami AM, Wani K, Al-Daghri NM. Reversal of Prediabetes in Saudi Adults: Results from an 18 Month Lifestyle Intervention. Nutrients 2020;12:E804. [PMID: 32197404 DOI: 10.3390/nu12030804] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
43 Bar-Tana J. Type 2 diabetes - unmet need, unresolved pathogenesis, mTORC1-centric paradigm. Rev Endocr Metab Disord 2020;21:613-29. [PMID: 32128655 DOI: 10.1007/s11154-020-09545-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
44 Pan S, Huang C, Chin W, Chen B, Chan C, Guo YL. Association between air pollution exposure and diabetic retinopathy among diabetics. Environmental Research 2020;181:108960. [DOI: 10.1016/j.envres.2019.108960] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
45 Guardado-Mendoza R, Salazar-López SS, Álvarez-Canales M, Farfán-Vázquez D, Martínez-López YE, Jiménez-Ceja LM, Suárez-Pérez EL, Angulo-Romero F, Evia-Viscarra ML, Montes de Oca-Loyola ML, Durán-Pérez EG, Folli F, Aguilar-García A. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial. Metabolism 2020;104:154054. [PMID: 31887309 DOI: 10.1016/j.metabol.2019.154054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
46 Al Amri T, Bahijri S, Al-Raddadi R, Ajabnoor G, Al Ahmadi J, Jambi H, Borai A, Tuomilehto J. The Association Between Prediabetes and Dyslipidemia Among Attendants of Primary Care Health Centers in Jeddah, Saudi Arabia. Diabetes Metab Syndr Obes 2019;12:2735-43. [PMID: 31920353 DOI: 10.2147/DMSO.S233717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
47 Gupta P, Man REK, Lamoureux EL. Retinopathy signs in non-diabetic individuals: to care or not to care. Clin Exp Ophthalmol 2019;47:1117-8. [PMID: 31865644 DOI: 10.1111/ceo.13693] [Reference Citation Analysis]
48 Fang F, Wang N, Yan S, Wang L, Lu Y, Li J, Li H, Pham G, Li C, Leng SX, Tian H. Impaired glucose tolerance predicts all-cause mortality among older men at high risk for cardiovascular disease in China. Primary Care Diabetes 2019;13:495-504. [DOI: 10.1016/j.pcd.2019.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Isola G, Matarese G, Ramaglia L, Pedullà E, Rapisarda E, Iorio-siciliano V. Association between periodontitis and glycosylated haemoglobin before diabetes onset: a cross-sectional study. Clin Oral Invest 2020;24:2799-808. [DOI: 10.1007/s00784-019-03143-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 16.7] [Reference Citation Analysis]
50 Mitra VV, Ram T, Neusha D, Sanghani S, Anusha Y, Tanv N. Incidence of Microvascular Complications in Newly Diagnosed Diabetes Mellitus. jebmh 2019;6:2760-2764. [DOI: 10.18410/jebmh/2019/573] [Reference Citation Analysis]
51 Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Diabetic Retinopathy Preferred Practice Pattern®. Ophthalmology 2020;127:P66-P145. [PMID: 31757498 DOI: 10.1016/j.ophtha.2019.09.025] [Cited by in Crossref: 144] [Cited by in F6Publishing: 162] [Article Influence: 48.0] [Reference Citation Analysis]
52 Sánchez E, Gutiérrez-Carrasquilla L, Barbé F, Betriu À, López-Cano C, Gaeta AM, Purroy F, Pamplona R, Ortega M, Fernández E, Hernández C, Lecube A, Simó R; ILERVAS Project. Lung function measurements in the prediabetes stage: data from the ILERVAS Project. Acta Diabetol 2019;56:1005-12. [PMID: 30989377 DOI: 10.1007/s00592-019-01333-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
53 Ng YL, Teoh SH, Mohd Radzniwan AR, Syahnaz MH. Prevalence and associated factors of undiagnosed glycaemic disorders in men with erectile dysfunction attending a primary care clinic. J Taibah Univ Med Sci 2019;14:88-94. [PMID: 31435395 DOI: 10.1016/j.jtumed.2018.12.002] [Reference Citation Analysis]
54 Mills LS. Diabetes, pregnancy and mental health: a tricky triad. British Journal of Midwifery 2019;27:491-496. [DOI: 10.12968/bjom.2019.27.8.491] [Reference Citation Analysis]
55 Mahat RK, Singh N, Arora M, Rathore V. Health risks and interventions in prediabetes: A review. Diabetes Metab Syndr 2019;13:2803-11. [PMID: 31405710 DOI: 10.1016/j.dsx.2019.07.041] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
56 Beckman JA, Duncan MS, Damrauer SM, Wells QS, Barnett JV, Wasserman DH, Bedimo RJ, Butt AA, Marconi VC, Sico JJ, Tindle HA, Bonaca MP, Aday AW, Freiberg MS. Microvascular Disease, Peripheral Artery Disease, and Amputation. Circulation 2019;140:449-58. [PMID: 31280589 DOI: 10.1161/CIRCULATIONAHA.119.040672] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 22.7] [Reference Citation Analysis]
57 Nathan DM, Bennett PH, Crandall JP, Edelstein SL, Goldberg RB, Kahn SE, Knowler WC, Mather KJ, Mudaliar S, Orchard TJ, Temprosa M, White NH; Research Group. Does diabetes prevention translate into reduced long-term vascular complications of diabetes? Diabetologia 2019;62:1319-28. [PMID: 31270584 DOI: 10.1007/s00125-019-4928-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
58 Sumbul HE, Koc AS, Gülümsek E. Renal cortical stiffness is markedly increased in pre-diabetes mellitus and associated with albuminuria. Singapore Med J 2020;61:435-42. [PMID: 31197376 DOI: 10.11622/smedj.2019052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
59 Pratte KA, Johnson A, Beals J, Bullock A, Manson SM, Jiang L; Special Diabetes Program for Indians Diabetes Prevention Program. Regression to Normal Glucose Regulation in American Indians and Alaska Natives of a Diabetes Prevention Program. Diabetes Care 2019;42:1209-16. [PMID: 31177184 DOI: 10.2337/dc18-1964] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
60 Khowailed EA, Seddiek HA, Mahmoud MM, Rashed LA, Ibrahim FE. Effect of metformin on Sirtuin-1 disorders associated with diabetes in male rats. Alexandria Journal of Medicine 2018;54:373-81. [DOI: 10.1016/j.ajme.2017.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
61 Hostalek U. Global epidemiology of prediabetes - present and future perspectives. Clin Diabetes Endocrinol 2019;5:5. [PMID: 31086677 DOI: 10.1186/s40842-019-0080-0] [Cited by in Crossref: 106] [Cited by in F6Publishing: 112] [Article Influence: 35.3] [Reference Citation Analysis]
62 Rett K, Gottwald-Hostalek U. Understanding prediabetes: definition, prevalence, burden and treatment options for an emerging disease. Curr Med Res Opin 2019;35:1529-34. [PMID: 30935247 DOI: 10.1080/03007995.2019.1601455] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
63 Bakiner OS, Bozkırlı E, Aksöyek A, Özşahin AK. Prediabetes: An Update and a Rational for Diagnostic Confusion. Turkish Journal of Family Medicine and Primary Care 2019. [DOI: 10.21763/tjfmpc.528045] [Reference Citation Analysis]
64 Metcalf KB. Can Obesity and Health Coexist? Nutr Today 2019;54:64-66. [DOI: 10.1097/nt.0000000000000328] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
65 Gunaid AA, Al-Kebsi MM, Bamashmus MA, Al-Akily SA, Al-Radaei AN. Clinical phenotyping of newly diagnosed type 2 diabetes in Yemen. BMJ Open Diabetes Res Care 2018;6:e000587. [PMID: 30613401 DOI: 10.1136/bmjdrc-2018-000587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
66 Anwar SB, Asif N, Naqvi SAH, Malik S. Evaluation of multiple risk factors involved in the development of Diabetic Retinopathy. Pak J Med Sci 2019;35:156-60. [PMID: 30881415 DOI: 10.12669/pjms.35.1.279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
67 Nah EH, Chu J, Kim S, Cho S, Kwon E. Efficacy of lifestyle interventions in the reversion to normoglycemia in Korean prediabetics: One-year results from a randomised controlled trial. Prim Care Diabetes 2019;13:212-20. [PMID: 30583933 DOI: 10.1016/j.pcd.2018.11.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
68 Park SK, Ryoo J, Oh C, Choi J, Choi Y, Lee KO, Jung JY. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES). Diabetes Research and Clinical Practice 2018;146:130-7. [DOI: 10.1016/j.diabres.2017.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
69 Grauslund J, Andersen N, Andresen J, Flesner P, Haamann P, Heegaard S, Larsen M, Laugesen CS, Schielke K, Skov J, Bek T. Evidence-based Danish guidelines for screening of diabetic retinopathy. Acta Ophthalmol 2018;96:763-9. [PMID: 30311394 DOI: 10.1111/aos.13936] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
70 Mechanick JI, Garber AJ, Grunberger G, Handelsman Y, Garvey WT. Dysglycemia-Based Chronic Disease: An American Association of Clinical Endocrinologists Position Statement. Endocrine Practice 2018;24:995-1011. [DOI: 10.4158/ps-2018-0139] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 11.0] [Reference Citation Analysis]
71 Braga T, Kraemer-Aguiar LG, Docherty NG, Le Roux CW. Treating prediabetes: why and how should we do it? Minerva Med 2019;110:52-61. [PMID: 30371047 DOI: 10.23736/S0026-4806.18.05897-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
72 Perreault L. GOALS FOR MEDICAL TREATMENT IN OBESITY AND PREDIABETES: IMPROVING OUTCOMES FOR BOTH. Endocr Pract 2018;24:1093-8. [PMID: 30289308 DOI: 10.4158/EP-2018-0316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Štechová K. Prediabetes. Interní Med 2018;20:183-188. [DOI: 10.36290/int.2018.033] [Reference Citation Analysis]
74 Stepanek L, Horakova D, Nakladalova M, Cibickova L, Karasek D, Zadrazil J. Significance of prediabetes as a nosological entity. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018. [PMID: 30255857 DOI: 10.5507/bp.2018.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Mangan A, Docherty NG, Le Roux CW, Al-Najim W. Current and emerging pharmacotherapy for prediabetes: are we moving forward? Expert Opin Pharmacother 2018;19:1663-73. [PMID: 30198813 DOI: 10.1080/14656566.2018.1517155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
76 Shukla AP, Dickison M, Coughlin N, Karan A, Mauer E, Truong W, Casper A, Emiliano AB, Kumar RB, Saunders KH, Igel LI, Aronne LJ. The impact of food order on postprandial glycaemic excursions in prediabetes. Diabetes Obes Metab 2019;21:377-81. [PMID: 30101510 DOI: 10.1111/dom.13503] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
77 Tong YZ, Tong NW, Teng WP, Mu YM, Zhao JJ, Shan ZY, Ning G; Chinese Society of Endocrinology. Consensus on the Prevention of Type 2 Diabetes in Chinese Adults. Chin Med J (Engl) 2017;130:600-6. [PMID: 28229993 DOI: 10.4103/0366-6999.200532] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
78 Sarfati D, McLeod M, Stanley J, Signal V, Stairmand J, Krebs J, Dowell A, Leung W, Davies C, Grainger R. BetaMe: impact of a comprehensive digital health programme on HbA1c and weight at 12 months for people with diabetes and pre-diabetes: study protocol for a randomised controlled trial. Trials 2018;19:161. [PMID: 29506562 DOI: 10.1186/s13063-018-2528-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
79 Perreault L. Prevention of Type 2 Diabetes. Contemporary Diabetes 2018. [DOI: 10.1007/978-3-319-61013-9_2] [Reference Citation Analysis]
80 Defronzo RA. Pathogenesis of Type 2 Diabetes Mellitus. Endocrinology 2018. [DOI: 10.1007/978-3-319-27317-4_8-1] [Reference Citation Analysis]
81 Defronzo RA. Pathogenesis of Type 2 Diabetes Mellitus. Endocrinology 2018. [DOI: 10.1007/978-3-319-45015-5_8] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
82 Ogurtsova K, Heise TL, Linnenkamp U, Dintsios CM, Lhachimi SK, Icks A. External validation of type 2 diabetes computer simulation models: definitions, approaches, implications and room for improvement-a protocol for a systematic review. Syst Rev 2017;6:267. [PMID: 29284543 DOI: 10.1186/s13643-017-0664-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
83 Đorđević B, Sokolović D, Cvetković T, Jevtović-stoimenov T, Despotović M, Veljković A, Bašić J, Đukić D, Stević N, Veličkov A, Milenković J, Milošević S. EFFECTS OF METFORMIN ON PARAMETERS OF OXIDATIVE DAMAGE IN THE RETINA OF RATS WITH IMPAIRED GLUCOSE TOLERANCE. amm 2017;56:75-82. [DOI: 10.5633/amm.2017.0412] [Reference Citation Analysis]
84 Hooper P, Boucher MC, Cruess A, Dawson KG, Delpero W, Greve M, Kozousek V, Lam WC, Maberley DAL. Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy. Can J Ophthalmol 2017;52 Suppl 1:S45-74. [PMID: 29074014 DOI: 10.1016/j.jcjo.2017.09.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
85 Khokhar A, Umpaichitra V, Chin VL, Perez-colon S. Metformin Use in Children and Adolescents with Prediabetes. Pediatric Clinics of North America 2017;64:1341-53. [DOI: 10.1016/j.pcl.2017.08.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
86 Zaleska-Żmijewska A, Piątkiewicz P, Śmigielska B, Sokołowska-Oracz A, Wawrzyniak ZM, Romaniuk D, Szaflik J, Szaflik JP. Retinal Photoreceptors and Microvascular Changes in Prediabetes Measured with Adaptive Optics (rtx1™): A Case-Control Study. J Diabetes Res 2017;2017:4174292. [PMID: 29238728 DOI: 10.1155/2017/4174292] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
87 Monti LD, Galluccio E, Villa V, Fontana B, Spadoni S, Piatti PM. Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study). Eur J Nutr 2018;57:2805-17. [PMID: 29052766 DOI: 10.1007/s00394-017-1548-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
88 Dolz M, Dhane Y. [Prediabetes, definition and treatment]. Soins 2017;62:11-6. [PMID: 29031374 DOI: 10.1016/j.soin.2017.08.002] [Reference Citation Analysis]
89 Vas PRJ, Alberti KG, Edmonds ME. Prediabetes: moving away from a glucocentric definition. Lancet Diabetes Endocrinol 2017;5:848-9. [PMID: 28781065 DOI: 10.1016/S2213-8587(17)30234-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
90 Perreault L, Færch K, Gregg EW. Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes? Curr Diab Rep 2017;17. [DOI: 10.1007/s11892-017-0899-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
91 Brannick B, Wynn A, Dagogo-Jack S. Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Exp Biol Med (Maywood) 2016;241:1323-31. [PMID: 27302176 DOI: 10.1177/1535370216654227] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 15.2] [Reference Citation Analysis]
92 Keel S, Xie J, Foreman J, van Wijngaarden P, Taylor HR, Dirani M. The Prevalence of Diabetic Retinopathy in Australian Adults with Self-Reported Diabetes: The National Eye Health Survey. Ophthalmology 2017;124:977-84. [PMID: 28318640 DOI: 10.1016/j.ophtha.2017.02.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 8.2] [Reference Citation Analysis]
93 Patel YR, Kirkman MS, Considine RV, Hannon TS, Mather KJ. Retinopathy predicts progression of fasting plasma glucose: An Early Diabetes Intervention Program (EDIP) analysis. J Diabetes Complications 2017;31:605-10. [PMID: 28003103 DOI: 10.1016/j.jdiacomp.2016.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
94 Strauss SM, McCarthy M. Arthritis-Related Limitations Predict Insufficient Physical Activity in Adults With Prediabetes Identified in the NHANES 2011-2014. Diabetes Educ 2017;43:163-70. [PMID: 28169593 DOI: 10.1177/0145721717691849] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
95 Nah EH, Cho S, Kim S, Cho HI. Comparison of Urine Albumin-to-Creatinine Ratio (ACR) Between ACR Strip Test and Quantitative Test in Prediabetes and Diabetes. Ann Lab Med 2017;37:28-33. [PMID: 27834062 DOI: 10.3343/alm.2017.37.1.28] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
96 Yazgan S, Arpaci D, Celik HU, Dogan M, Isık I. Macular Choroidal Thickness May Be the Earliest Determiner to Detect the Onset of Diabetic Retinopathy in Patients with Prediabetes: A Prospective and Comparative Study. Curr Eye Res 2017;42:1039-47. [PMID: 28121176 DOI: 10.1080/02713683.2016.1264606] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
97 . New data from the FIELD study: protecting the diabetic eye. Diabetes and Vascular Disease Research 2007;4:S1-7. [DOI: 10.3132/dvdr.2007.069] [Reference Citation Analysis]
98 Insulin Resistance and Type 2 Diabetes in Pediatric Populations. Childhood Obesity 2016. [DOI: 10.1201/9781315370958-26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
99 Zhang R, Li Y, Zhang S, Cai X, Zhou X, Ji L. The Association of Retinopathy and Plasma Glucose and HbA1c: A Validation of Diabetes Diagnostic Criteria in a Chinese Population. J Diabetes Res 2016;2016:4034129. [PMID: 27807545 DOI: 10.1155/2016/4034129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
100 Edwards CM, Cusi K. Prediabetes: A Worldwide Epidemic. Endocrinol Metab Clin North Am 2016;45:751-64. [PMID: 27823603 DOI: 10.1016/j.ecl.2016.06.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 6.5] [Reference Citation Analysis]
101 Kumar R, Nandhini LP, Kamalanathan S, Sahoo J, Vivekanadan M. Evidence for current diagnostic criteria of diabetes mellitus. World J Diabetes 2016; 7(17): 396-405 [PMID: 27660696 DOI: 10.4239/wjd.v7.i17.396] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
102 Okosun IS, Turbow S, McJenkin K, Monique Davis-Smith Y, Seale JP. Diagnostic performance of glycated hemoglobin for diabetic retinopathy in non-diabetic older overweight/obese African-Americans. Diabetes Res Clin Pract 2016;120:124-31. [PMID: 27544907 DOI: 10.1016/j.diabres.2016.07.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
103 Ponto KA, Koenig J, Peto T, Lamparter J, Raum P, Wild PS, Lackner KJ, Pfeiffer N, Mirshahi A. Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS). Diabetologia 2016;59:1913-9. [PMID: 27314413 DOI: 10.1007/s00125-016-4013-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
104 Kong AP, Luk AO, Chan JC. Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated? Best Practice & Research Clinical Endocrinology & Metabolism 2016;30:345-55. [DOI: 10.1016/j.beem.2016.06.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
105 Pusparajah P, Lee LH, Abdul Kadir K. Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future? Front Physiol 2016;7:200. [PMID: 27313539 DOI: 10.3389/fphys.2016.00200] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
106 Meijnikman AS, De Block CE, Verrijken A, Mertens I, Corthouts B, Van Gaal LF. Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score. J Diabetes Complications 2016;30:1043-9. [PMID: 27217020 DOI: 10.1016/j.jdiacomp.2016.05.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
107 Martínez-Vizcaíno V, Cavero-Redondo I, Álvarez-Bueno C, Rodríguez-Artalejo F. The Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0154411. [PMID: 27123641 DOI: 10.1371/journal.pone.0154411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
108 Hostalek U, Gwilt M, Hildemann S. Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention. Drugs 2015;75:1071-94. [PMID: 26059289 DOI: 10.1007/s40265-015-0416-8] [Cited by in Crossref: 143] [Cited by in F6Publishing: 109] [Article Influence: 23.8] [Reference Citation Analysis]
109 Manaf A, Tjandrawinata RR, Malinda D. Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa. Drug Des Devel Ther 2016;10:1279-89. [PMID: 27099473 DOI: 10.2147/DDDT.S97568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
110 Ceccarini G, Ciccarone AM, Santini F, Del Prato S. Integrating medical and surgical therapies to optimize the outcomes of type 2 diabetes. Surg Obes Relat Dis 2016;12:1186-91. [PMID: 27178605 DOI: 10.1016/j.soard.2016.01.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
111 Aguirre GA, De Ita JR, de la Garza RG, Castilla-Cortazar I. Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med. 2016;14:3. [PMID: 26733412 DOI: 10.1186/s12967-015-0762-z] [Cited by in Crossref: 141] [Cited by in F6Publishing: 152] [Article Influence: 23.5] [Reference Citation Analysis]
112 Ziemssen F, Agostini HT. Diabetic Retinopathy. Anti-Angiogenic Therapy in Ophthalmology 2016. [DOI: 10.1007/978-3-319-24097-8_6] [Reference Citation Analysis]
113 Dennedy MC, Rizza RA, Dinneen SF. Classification and Diagnosis of Diabetes Mellitus. Endocrinology: Adult and Pediatric 2016. [DOI: 10.1016/b978-0-323-18907-1.00038-x] [Reference Citation Analysis]
114 Mills L, Palmer C, Arya R. Reducing diabetes-related complications in pregnancy. British Journal of Midwifery 2015;23:848-853. [DOI: 10.12968/bjom.2015.23.12.848] [Reference Citation Analysis]
115 Deepa M, Grace M, Binukumar B, Pradeepa R, Roopa S, Khan HM, Fatmi Z, Kadir MM, Naeem I, Ajay VS, Anjana RM, Ali MK, Prabhakaran D, Tandon N, Mohan V, Narayan KM; CARRS Surveillance Research Group. High burden of prediabetes and diabetes in three large cities in South Asia: The Center for cArdio-metabolic Risk Reduction in South Asia (CARRS) Study. Diabetes Res Clin Pract 2015;110:172-82. [PMID: 26432412 DOI: 10.1016/j.diabres.2015.09.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
116 Kanat M, DeFronzo RA, Abdul-Ghani MA. Treatment of prediabetes. World J Diabetes 2015; 6(12): 1207-1222 [PMID: 26464759 DOI: 10.4239/wjd.v6.i12.1207] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
117 Ates I, Kaplan M, Inan B, Alisik M, Erel O, Yilmaz N, Guler S. How does thiol/disulfide homeostasis change in prediabetic patients? Diabetes Res Clin Pract. 2015;110:166-171. [PMID: 26421363 DOI: 10.1016/j.diabres.2015.09.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
118 Sun Z, He J, Qiu S, Lei C, Zhou Y, Xie Z, Zhang L, Wang Y, Jin H. Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects. PLoS One 2015;10:e0137756. [PMID: 26368827 DOI: 10.1371/journal.pone.0137756] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
119 Lu J, Hou X, Zhang L, Jiang F, Hu C, Bao Y, Jia W. Association between body mass index and diabetic retinopathy in Chinese patients with type 2 diabetes. Acta Diabetol 2015;52:701-8. [PMID: 25604042 DOI: 10.1007/s00592-014-0711-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
120 Chen SC, Hsiao PJ, Huang JC, Lin KD, Hsu WH, Lee YL, Lee MY, Chang JM, Shin SJ. Abnormally Low or High Ankle-Brachial Index Is Associated with Proliferative Diabetic Retinopathy in Type 2 Diabetic Mellitus Patients. PLoS One 2015;10:e0134718. [PMID: 26230390 DOI: 10.1371/journal.pone.0134718] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
121 Fatemi A, Iraj B, Barzanian J, Maracy M, Smiley A. Musculoskeletal manifestations in diabetic versus prediabetic patients. Int J Rheum Dis 2015;18:791-9. [PMID: 26176709 DOI: 10.1111/1756-185X.12712] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
122 Ghody P, Shikha D, Karam J, Bahtiyar G. Identifying prediabetes – Is it beneficial in the long run? Maturitas 2015;81:282-6. [DOI: 10.1016/j.maturitas.2015.03.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
123 Penman A, Hoadley S, Wilson JG, Taylor HA, Chen CJ, Sobrin L. P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans. Am J Ophthalmol 2015;159:1152-1160.e2. [PMID: 25794792 DOI: 10.1016/j.ajo.2015.03.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
124 Bao C, Zhang D, Sun B, Lan L, Cui W, Xu G, Sui C, Wang Y, Zhao Y, Wang J, Li H. Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China. PLoS One 2015;10:e0119510. [PMID: 25785585 DOI: 10.1371/journal.pone.0119510] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
125 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 242] [Cited by in F6Publishing: 256] [Article Influence: 34.6] [Reference Citation Analysis]
126 B PR, G RLB, G RSK, K V V S. STUDY OF THE PREVALENCE OF MICROALBUMINURIA AND RETINOPATHY IN PREDIABETES IN A TERTIARY CARE HOSPITAL. jebmh 2015;2:608-614. [DOI: 10.18410/jebmh/2015/87] [Reference Citation Analysis]
127 Lalla E, Cheng B, Kunzel C, Burkett S, Ferraro A, Lamster IB. Six-month outcomes in dental patients identified with hyperglycaemia: a randomized clinical trial. J Clin Periodontol 2015;42:228-35. [DOI: 10.1111/jcpe.12358] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
128 Lu J, Hou X, Zhang L, Hu C, Zhou J, Pang C, Pan X, Bao Y, Jia W. Associations between clinical characteristics and chronic complications in latent autoimmune diabetes in adults and type 2 diabetes. Diabetes Metab Res Rev 2015;31:411-20. [PMID: 25448723 DOI: 10.1002/dmrr.2626] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
129 Tsimihodimos V, Florentin M. Hypertension and Dyslipidemia in Patients with Pre-Diabetes. Glucose Intake and Utilization in Pre-Diabetes and Diabetes 2015. [DOI: 10.1016/b978-0-12-800093-9.00013-2] [Reference Citation Analysis]
130 Zhang W, Shen S, Wang W, Zhou C, Xu L, Qiu J, Wang J, Meng X, Liang Y, Niu K, Guo Q. Poor lower extremity function was associated with pre-diabetes and diabetes in older chinese people. PLoS One 2014;9:e115883. [PMID: 25531769 DOI: 10.1371/journal.pone.0115883] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
131 Liccardo D, Mosca A, Petroni S, Valente P, Giordano U, Mico' AG, Pescosolido S, Buzzonetti L, Nobili V. The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD). J Gastroenterol 2015;50:903-12. [PMID: 25516385 DOI: 10.1007/s00535-014-1024-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
132 Strauss SM, Rosedale M, Pesce MA, Juterbock C, Kaur N, DePaola J, Goetz D, Wolff MS, Malaspina D, Danoff A. Point-of-Care HbA1c Testing with the A1cNow Test Kit in General Practice Dental Clinics: A Pilot Study Involving Its Accuracy and Practical Issues in Its Use. Point Care 2014;13:142-7. [PMID: 25593546 DOI: 10.1097/POC.0000000000000039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
133 Bhargava M, Cheung CY, Sabanayagam C, Huang L, Lamoureux EL, Wang JJ, Tai ES, Heng CK, Ikram MK, Mitchell P, Wong TY. Prevalence and risk factors for retinopathy in persons without diabetes: the Singapore Indian Eye Study. Acta Ophthalmol 2014;92:e602-9. [PMID: 24894034 DOI: 10.1111/aos.12446] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
134 Tomkin GH. Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors. World J Diabetes 2014; 5(5): 636-650 [PMID: 25317241 DOI: 10.4239/wjd.v5.i5.636] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
135 Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine 2015;48:371-93. [PMID: 25294012 DOI: 10.1007/s12020-014-0436-2] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 11.1] [Reference Citation Analysis]
136 Daniele G, Abdul-Ghani M, DeFronzo RA. What are the pharmacotherapy options for treating prediabetes? Expert Opin Pharmacother 2014;15:2003-18. [PMID: 25139488 DOI: 10.1517/14656566.2014.944160] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
137 Rosberger DF. Diabetic retinopathy: current concepts and emerging therapy.Endocrinol Metab Clin North Am. 2013;42:721-745. [PMID: 24286948 DOI: 10.1016/j.ecl.2013.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
138 Perreault L, Temprosa M, Mather KJ, Horton E, Kitabchi A, Larkin M, Montez MG, Thayer D, Orchard TJ, Hamman RF. Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. Diabetes Care. 2014;37:2622-2631. [PMID: 24969574 DOI: 10.2337/dc14-0656] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 9.6] [Reference Citation Analysis]
139 Boyer DS, Hopkins JJ, Sorof J, Ehrlich JS. Anti-vascular endothelial growth factor therapy for diabetic macular edema. Ther Adv Endocrinol Metab. 2013;4:151-169. [PMID: 24324855 DOI: 10.1177/2042018813512360] [Cited by in Crossref: 105] [Cited by in F6Publishing: 118] [Article Influence: 13.1] [Reference Citation Analysis]
140 Soliman A, DeSanctis V, Yassin M, Elalaily R, Eldarsy NE. Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups. Indian J Endocrinol Metab 2014;18:274-82. [PMID: 24944918 DOI: 10.4103/2230-8210.131130] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
141 Mainous AG 3rd, Tanner RJ, Baker R, Zayas CE, Harle CA. Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study. BMJ Open 2014;4:e005002. [PMID: 24913327 DOI: 10.1136/bmjopen-2014-005002] [Cited by in Crossref: 114] [Cited by in F6Publishing: 119] [Article Influence: 14.3] [Reference Citation Analysis]
142 Huang J, Ou HY, Karnchanasorn R, Samoa R, Chuang LM, Chiu KC, Feng W. Clinical implication of fasting and post-challenged plasma glucose in diagnosis of diabetes mellitus. Endocrine 2015;48:511-8. [PMID: 24895042 DOI: 10.1007/s12020-014-0301-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
143 Park YM, Ko SH, Lee JM, Kim DJ, Kim DJ, Han K, Bower JK, Ahn YB; Committee of Clinical Practice Guideline, Korean Diabetes Association. Glycaemic and haemoglobin A1c thresholds for detecting diabetic retinopathy: the fifth Korea National Health and Nutrition Examination Survey (2011). Diabetes Res Clin Pract 2014;104:435-42. [PMID: 24785739 DOI: 10.1016/j.diabres.2014.04.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
144 Bilir BE, Atile NS, Bilir B, Guldiken S, Tuncbilek N, Puyan FO, Sezer A, Coskun I. A metabolic syndrome case presenting with lymphocytic mastitis. Breast Care (Basel) 2012;7:493-5. [PMID: 24715834 DOI: 10.1159/000345474] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
145 Lalla E, Wolf D, Lamster IB. Identification of dental patients with undiagnosed diabetes. Diabetes Mellitus and Oral Health 2014. [DOI: 10.1002/9781118887837.ch9] [Reference Citation Analysis]
146 Abcouwer SF, Gardner TW. Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci. 2014;1311:174-190. [PMID: 24673341 DOI: 10.1111/nyas.12412] [Cited by in Crossref: 124] [Cited by in F6Publishing: 140] [Article Influence: 15.5] [Reference Citation Analysis]
147 Ghosh P, Vaidya A, Sahoo R, Goldfine A, Herring N, Bry L, Chorev M, Halperin JA. Glycation of the complement regulatory protein CD59 is a novel biomarker for glucose handling in humans. J Clin Endocrinol Metab 2014;99:E999-E1006. [PMID: 24628556 DOI: 10.1210/jc.2013-4232] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
148 Lee LT, Alexandrov AW, Howard VJ, Kabagambe EK, Hess MA, McLain RM, Safford MM, Howard G. Race, regionality and pre-diabetes in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Prev Med 2014;63:43-7. [PMID: 24594101 DOI: 10.1016/j.ypmed.2014.02.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
149 Lamparter J, Raum P, Pfeiffer N, Peto T, Höhn R, Elflein H, Wild P, Schulz A, Schneider A, Mirshahi A. Prevalence and associations of diabetic retinopathy in a large cohort of prediabetic subjects: the Gutenberg Health Study. J Diabetes Complications. 1989;28:482-487. [PMID: 24630763 DOI: 10.1016/j.jdiacomp.2014.02.008] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
150 Higashikawa F, Noda M, Awaya T, Tanaka T, Sugiyama M. 5-aminolevulinic acid, a precursor of heme, reduces both fasting and postprandial glucose levels in mildly hyperglycemic subjects. Nutrition 2013;29:1030-6. [PMID: 23759263 DOI: 10.1016/j.nut.2013.02.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
151 Chakrabarti R, Harper CA, Keeffe JE. Diabetic retinopathy management guidelines. Expert Review of Ophthalmology 2014;7:417-39. [DOI: 10.1586/eop.12.52] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 6.8] [Reference Citation Analysis]
152 Today Study Group. Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Care. 2013;36:1772-1774. [PMID: 23704677 DOI: 10.2337/dc12-2387] [Cited by in Crossref: 87] [Cited by in F6Publishing: 92] [Article Influence: 9.7] [Reference Citation Analysis]
153 Blagosklonny MV. TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists. Cell Death Dis 2013;4:e964. [PMID: 24336084 DOI: 10.1038/cddis.2013.506] [Cited by in Crossref: 89] [Cited by in F6Publishing: 91] [Article Influence: 9.9] [Reference Citation Analysis]
154 Oka R, Aizawa T, Yagi K, Hayashi K, Kawashiri M, Yamagishi M. Elevated liver enzymes are related to progression to impaired glucose tolerance in Japanese men. Diabet Med 2014;31:552-8. [DOI: 10.1111/dme.12345] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
155 Perreault L, Færch K. Approaching pre-diabetes. J Diabetes Complications 2014;28:226-33. [PMID: 24342268 DOI: 10.1016/j.jdiacomp.2013.10.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
156 Gerstein HC, Werstuck GH. Dysglycaemia, vasculopenia, and the chronic consequences of diabetes. The Lancet Diabetes & Endocrinology 2013;1:71-8. [DOI: 10.1016/s2213-8587(13)70025-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
157 Pratley RE. The early treatment of type 2 diabetes. Am J Med 2013;126:S2-9. [PMID: 23953075 DOI: 10.1016/j.amjmed.2013.06.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
158 Lalla E, Cheng B, Kunzel C, Burkett S, Lamster I. Dental Findings and Identification of Undiagnosed Hyperglycemia. J Dent Res 2013;92:888-92. [DOI: 10.1177/0022034513502791] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
159 Erdogan D, Yucel H, Uysal BA, Ersoy IH, Icli A, Akcay S, Arslan A, Aksoy F, Ozaydin M, Tamer MN. Effects of prediabetes and diabetes on left ventricular and coronary microvascular functions. Metabolism 2013;62:1123-30. [DOI: 10.1016/j.metabol.2013.02.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
160 Buysschaert M, Bergman M. Diagnosis of Prediabetes and Diabetes Prevention. Prevention of Diabetes 2013. [DOI: 10.1002/9781118661321.ch3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
161 Werzowa J, Hecking M, Haidinger M, Lechner F, Döller D, Pacini G, Stemer G, Pleiner J, Frantal S, Säemann MD. Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial. Transplantation. 2013;95:456-462. [PMID: 23380864 DOI: 10.1097/tp.0b013e318276a20e] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
162 Lee PG, Cigolle CT, Ha J, Min L, Murphy SL, Blaum CS, Herman WH. Physical function limitations among middle-aged and older adults with prediabetes: one exercise prescription may not fit all. Diabetes Care 2013;36:3076-83. [PMID: 23757432 DOI: 10.2337/dc13-0412] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
163 Tuttle KR, Tuot DS, Corbett CL, Setter SM, Powe NR. Type 2 translational research for CKD. Clin J Am Soc Nephrol 2013;8:1829-38. [PMID: 23620444 DOI: 10.2215/CJN.00130113] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
164 Huang S, Dang H, Huynh W, Sambrook PJ, Goss AN. The healing of dental extraction sockets in patients with Type 2 diabetes on oral hypoglycaemics: a prospective cohort. Aust Dent J 2013;58:89-93. [PMID: 23441797 DOI: 10.1111/adj.12029] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
165 Yuan MX, Peng ZH, Xin Z, Feng JP, Hua L, Shi J, Geng K, Xu ZX, Zhu XR, Cao X, Liu C, Yang JK. Low prevalence of diabetic retinopathy in a Chinese population. Diabetes Care 2012;35:e61. [PMID: 22826454 DOI: 10.2337/dc12-0600] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
166 Dankner R, Chetrit A, Shanik M, Raz I, Roth J. Basal state hyperinsulinemia in healthy normoglycemic adults heralds dysglycemia after more than two decades of follow up: Hyperinsulinemia Heralds Dysglycemia. Diabetes Metab Res Rev 2012;28:618-24. [DOI: 10.1002/dmrr.2322] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
167 Unger J. Intensification of Type 2 Diabetes in Adolescents: Guess What? Exercise Wins! Clinical Diabetes 2012;30:164-167. [DOI: 10.2337/diaclin.30.4.164] [Reference Citation Analysis]
168 Tankova T, Chakarova N, Dakovska L, Atanassova I. Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes. Acta Diabetol 2012;49:371-8. [PMID: 21964885 DOI: 10.1007/s00592-011-0334-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
169 Lalla E, Lamster IB. Assessment and management of patients with diabetes mellitus in the dental office. Dent Clin North Am 2012;56:819-29. [PMID: 23017553 DOI: 10.1016/j.cden.2012.07.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
170 Hooper P, Boucher MC, Cruess A, Dawson KG, Delpero W, Greve M, Kozousek V, Lam WC, Maberley DA. Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy. Can J Ophthalmol 2012;47:S1-30, S31-54. [PMID: 22632804 DOI: 10.1016/j.jcjo.2011.12.025] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
171 Simmons LR, Molyneaux L, Yue DK, Chua EL. Steroid-induced diabetes: is it just unmasking of type 2 diabetes? ISRN Endocrinol 2012;2012:910905. [PMID: 22830041 DOI: 10.5402/2012/910905] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
172 Souza CFD, Gross JL, Gerchman F, Leitão CB. Pré-diabetes: diagnóstico, avaliação de complicações crônicas e tratamento. Arq Bras Endocrinol Metab 2012;56:275-84. [DOI: 10.1590/s0004-27302012000500001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
173 Pang C, Jia L, Jiang S, Liu W, Hou X, Zuo Y, Gu H, Bao Y, Wu Q, Xiang K, Gao X, Jia W. Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diabetes Metab Res Rev 2012;28:276-83. [PMID: 22139892 DOI: 10.1002/dmrr.1307] [Cited by in Crossref: 48] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
174 Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE; Diabetes Prevention Program Research Group. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012;379:2243-51. [PMID: 22683134 DOI: 10.1016/S0140-6736(12)60525-X] [Cited by in Crossref: 288] [Cited by in F6Publishing: 313] [Article Influence: 28.8] [Reference Citation Analysis]
175 Furtado de Souza C, Dalzochio MB, de Oliveira FJ, Gross JL, Leitão CB. Glucose tolerance status is a better predictor of diabetes and cardiovascular outcomes than metabolic syndrome: a prospective cohort study. Diabetol Metab Syndr 2012;4:25. [PMID: 22682107 DOI: 10.1186/1758-5996-4-25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
176 Sundling V, Platou CG, Jansson RW, Bertelsen G, Wøllo E, Gulbrandsen P. Retinopathy and visual impairment in diabetes, impaired glucose tolerance and normal glucose tolerance: the Nord-Trøndelag Health Study (the HUNT study). Acta Ophthalmol 2012;90:237-43. [PMID: 20809910 DOI: 10.1111/j.1755-3768.2010.01998.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
177 Chiasson J, Laakso M, Hanefeld M. Decreasing Postprandial Plasma Glucose Using an α-Glucosidase Inhibitor in Subjects with IGT for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial. In: Leroith D, editor. Prevention of Type 2 Diabetes. New York: Springer; 2012. pp. 167-87. [DOI: 10.1007/978-1-4614-3314-9_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
178 Chen X, Zhao Y, Zhou Z, Zhang X, Li Q, Bai L, Zhang M. Prevalence and risk factors of diabetic retinopathy in Chongqing pre-diabetes patients. Eye (Lond) 2012;26:816-20. [PMID: 22441028 DOI: 10.1038/eye.2012.50] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
179 Aroda VR, Ratner RE. Interventional Trials to Prevent Diabetes: Diabetes Prevention Program. Prevention of Type 2 Diabetes 2012. [DOI: 10.1007/978-1-4614-3314-9_9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
180 Su XD, Li SS, Tian YQ, Zhang ZY, Zhang GZ, Wang LX. Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes. Arch Med Res 2011;42:596-601. [PMID: 22100610 DOI: 10.1016/j.arcmed.2011.11.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
181 Strauss SM, Tuthill J, Singh G, Rindskopf D, Maggiore JA, Schoor R, Brodsky A, Einhorn A, Hochstein A, Russell S, Rosedale M. A novel intraoral diabetes screening approach in periodontal patients: results of a pilot study. J Periodontol 2012;83:699-706. [PMID: 22087806 DOI: 10.1902/jop.2011.110386] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
182 Moutzouri E, Tsimihodimos V, Rizos E, Elisaf M. Prediabetes: to treat or not to treat? Eur J Pharmacol. 2011;672:9-19. [PMID: 22020287 DOI: 10.1016/j.ejphar.2011.10.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
183 Su X, Meng X, Sun C, Liu L, Su B. Intramuscular injection of soluble receptor for advanced glycation endproducts expression vector prevents the development of streptozotocin-induced diabetes mellitus in rats on high fat diet. J Diabetes 2011;3:309-16. [PMID: 21883977 DOI: 10.1111/j.1753-0407.2011.00153.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
184 Hanefeld M, Schaper F. Drug therapy for the prevention of type 2 diabetes – is there a medical rationale? Diabetes & Vascular Disease 2011;11:168-74. [DOI: 10.1177/1474651411403987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
185 DeFronzo RA, Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 2011;108:3B-24B. [PMID: 21802577 DOI: 10.1016/j.amjcard.2011.03.013] [Cited by in Crossref: 202] [Cited by in F6Publishing: 219] [Article Influence: 18.4] [Reference Citation Analysis]
186 Sullivan SD, Ratner RE. Should the metabolic syndrome patient with prediabetes be offered pharmacotherapy? Curr Diab Rep 2011;11:91-8. [PMID: 21207204 DOI: 10.1007/s11892-010-0170-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
187 Abdul-Ghani MA, Abdul-Ghani T, Stern MP, Karavic J, Tuomi T, Bo I, Defronzo RA, Groop L. Two-step approach for the prediction of future type 2 diabetes risk. Diabetes Care 2011;34:2108-12. [PMID: 21788628 DOI: 10.2337/dc10-2201] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
188 DeFronzo RA, Abdul-Ghani M. Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care 2011;34 Suppl 2:S202-9. [PMID: 21525456 DOI: 10.2337/dc11-s221] [Cited by in Crossref: 94] [Cited by in F6Publishing: 102] [Article Influence: 8.5] [Reference Citation Analysis]
189 Chiasson J, Bernard S. Reducing cardiovascular risk factors in patients with prediabetes. Diabetes Management 2011;1:423-438. [DOI: 10.2217/dmt.11.28] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
190 Wanner C, Krane V. Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus. Kidney Blood Press Res. 2011;34:209-217. [PMID: 21691123 DOI: 10.1159/000326849] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
191 Testa R, Olivieri F, Ceriello A, La Sala L. Biologia dell’invecchiamento. Riv Ital Med Lab 2011;7:65-72. [DOI: 10.1007/s13631-011-0010-3] [Reference Citation Analysis]
192 Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KM. Screening for type 2 diabetes and dysglycemia. Epidemiol Rev 2011;33:63-87. [PMID: 21624961 DOI: 10.1093/epirev/mxq020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
193 Rani PK, Raman R, Gupta A, Pal SS, Kulothungan V, Sharma T. Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12). Diabetol Metab Syndr 2011;3:9. [PMID: 21612596 DOI: 10.1186/1758-5996-3-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
194 Lalla E, Kunzel C, Burkett S, Cheng B, Lamster I. Identification of Unrecognized Diabetes and Pre-diabetes in a Dental Setting. J Dent Res 2011;90:855-60. [DOI: 10.1177/0022034511407069] [Cited by in Crossref: 140] [Cited by in F6Publishing: 145] [Article Influence: 12.7] [Reference Citation Analysis]
195 Player MS, Diaz VA, Mainous AG 3rd, Gregorie SH, Knoll ME, Everett CJ. Ethnic differences in the relationship of prediabetes with the presence of target-organ disease. Diabetes Metab 2011;37:403-9. [PMID: 21459647 DOI: 10.1016/j.diabet.2010.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
196 Massin P, Lange C, Tichet J, Vol S, Erginay A, Cailleau M, Eschwège E, Balkau B. Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study. Arch Ophthalmol. 2011;129:188-195. [PMID: 21320965 DOI: 10.1001/archophthalmol.2010.353] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
197 Ratner RE, Sathasivam A. Treatment recommendations for prediabetes. Med Clin North Am 2011;95:385-95, viii-ix. [PMID: 21281840 DOI: 10.1016/j.mcna.2010.11.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
198 Milman S, Crandall JP. Mechanisms of vascular complications in prediabetes. Med Clin North Am 2011;95:309-25, vii. [PMID: 21281835 DOI: 10.1016/j.mcna.2010.11.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
199 Buysschaert M, Bergman M. Definition of prediabetes. Med Clin North Am. 2011;95:289-297, vii. [PMID: 21281833 DOI: 10.1016/j.mcna.2010.11.002] [Cited by in Crossref: 96] [Cited by in F6Publishing: 108] [Article Influence: 8.7] [Reference Citation Analysis]
200 Muthusamy K, Vella A. Is Prediabetes a Risk Factor or is it a Disease? Clinical Dilemmas in Diabetes 2011. [DOI: 10.1002/9781444340280.ch1] [Reference Citation Analysis]
201 Napoli N, Costanza F, Di Stasio E, Strollo R, Manfrini S, Cipponeri E, Picardi A, Carrano F, Dell'Anna V, Macino W, Pozzilli P. Blood glucose monitoring in the normal population: the PREDICA study. Acta Diabetol 2011;48:29-34. [PMID: 20703502 DOI: 10.1007/s00592-010-0212-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
202 Wan Q, Wang F, Wang F, Guan Q, Liu Y, Wang C, Feng L, Gao G, Gao L, Zhao J. Regression to normoglycaemia by fenofibrate in pre-diabetic subjects complicated with hypertriglyceridaemia: a prospective randomized controlled trial. Diabet Med 2010;27:1312-7. [PMID: 20968112 DOI: 10.1111/j.1464-5491.2010.03107.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
203 Wien M, Bleich D, Raghuwanshi M, Gould-Forgerite S, Gomes J, Monahan-Couch L, Oda K. Almond consumption and cardiovascular risk factors in adults with prediabetes. J Am Coll Nutr 2010;29:189-97. [PMID: 20833991 DOI: 10.1080/07315724.2010.10719833] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 7.1] [Reference Citation Analysis]
204 Pour OR, Dagogo-Jack S. Prediabetes as a therapeutic target. Clin Chem 2011;57:215-20. [PMID: 21062906 DOI: 10.1373/clinchem.2010.149096] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
205 Gong Q, Gregg EW, Wang J, An Y, Zhang P, Yang W, Li H, Li H, Jiang Y, Shuai Y. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia. 2011;54:300-307. [PMID: 21046360 DOI: 10.1007/s00125-010-1948-9] [Cited by in Crossref: 151] [Cited by in F6Publishing: 134] [Article Influence: 12.6] [Reference Citation Analysis]
206 Testa R, Bonfigli AR, Marra M, Testa I. In the Light of the Metabolic Memory Theory, Should Not All Aged People with Dysglycemia Be Treated? Rejuvenation Research 2010;13:599-605. [DOI: 10.1089/rej.2010.1024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
207 . Diagnosis and Classification of Diabetes. Handbook of Diabetes 2010. [DOI: 10.1002/9781444391374.ch3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
208 Hsueh WA, Orloski L, Wyne K. Prediabetes: the importance of early identification and intervention. Postgrad Med 2010;122:129-43. [PMID: 20675976 DOI: 10.3810/pgm.2010.07.2180] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
209 Jonas JB, Xu L, Xie XW, Wang YX. RELATIONSHIP BETWEEN FASTING GLUCOSE AND RETINOPATHY FOR DIAGNOSIS OF DIABETES: Results From a Population-Based Study in Urban and Rural China. Retina 2010;30:1223-7. [DOI: 10.1097/iae.0b013e3181ce74ae] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
210 Bloomgarden ZT. Cardiovascular disease in diabetes. Diabetes Care 2010;33:e49-54. [PMID: 20351221 DOI: 10.2337/dc10-zb04] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
211 Ghosh S, Collier A, Elhadd T, Malik I. Retinopathy in prediabetes. Diabetes & Vascular Disease 2010;10:155-6. [DOI: 10.1177/1474651409361427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
212 De Caterina R, Madonna R. Impaired fasting plasma glucose and long-term cardiovascular risk: still a foggy relationship. Eur Heart J 2010;31:1159-62. [PMID: 20418342 DOI: 10.1093/eurheartj/ehp589] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
213 Fruchart J, Sacks FM, Hermans MP, Assmann G, Brown W, Ceska R, Chapman M, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche J, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P. Residual Risk Reduction Initiative: výzva ke snížení reziduálního vaskulárního rizika u pacientů s dyslipidemií. Cor Vasa 2010;52:212-228. [DOI: 10.33678/cor.2010.056] [Reference Citation Analysis]
214 DeFronzo RA. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going. Am J Med 2010;123:S38-48. [PMID: 20206731 DOI: 10.1016/j.amjmed.2009.12.008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
215 Putz Z, Kempler P, Jermendy G. [Diabetes-specific complications in prediabetes]. Orv Hetil 2009;150:2139-45. [PMID: 19910279 DOI: 10.1556/OH.2009.28748] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
216 Langer O. Changing the diagnosis criteria of type 2 diabetes in pregnancy: do the ends justify the means? The Journal of Maternal-Fetal & Neonatal Medicine 2010;23:234-8. [DOI: 10.3109/14767050903550907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
217 Garber AJ. Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy. Diabetes Care 2009;32 Suppl 2:S184-8. [PMID: 19875549 DOI: 10.2337/dc09-S307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
218 Cheng YJ, Gregg EW, Geiss LS, Imperatore G, Williams DE, Zhang X, Albright AL, Cowie CC, Klein R, Saaddine JB. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds. Diabetes Care. 2009;32:2027-2032. [PMID: 19875604 DOI: 10.2337/dc09-0440] [Cited by in Crossref: 103] [Cited by in F6Publishing: 114] [Article Influence: 8.6] [Reference Citation Analysis]
219 Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010;87:415-421. [PMID: 20061043 DOI: 10.1016/j.diabres.2009.12.013] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 8.0] [Reference Citation Analysis]
220 Handelsman Y, Abby SL, Jin X, Donovan JM, Jones MR. Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes. Postgrad Med 2009;121:62-9. [PMID: 19940418 DOI: 10.3810/pgm.2009.11.2078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
221 Dinneen SF, Rizza RA. Classification and Diagnosis of Diabetes Mellitus. Endocrinology 2010. [DOI: 10.1016/b978-1-4160-5583-9.00039-3] [Reference Citation Analysis]
222 Johnson JL, Duick DS, Chui MA, Aldasouqi SA. Identifying Prediabetes Using Fasting Insulin Levels. Endocrine Practice 2010;16:47-52. [DOI: 10.4158/ep09031.or] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
223 Peng XY, Wang FH, Liang YB, Wang JJ, Sun LP, Peng Y, Friedman DS, Liew G, Wang NL, Wong TY. Retinopathy in persons without diabetes: the Handan Eye Study. Ophthalmology 2010;117:531-7, 537.e1-2. [PMID: 20036013 DOI: 10.1016/j.ophtha.2009.07.045] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
224 DeFronzo RA, Banerji MA, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven P, Schwenke DC, Stentz FD, Tripathy D; ACT NOW Study Group. Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study. Diabetologia 2010;53:435-45. [PMID: 20012012 DOI: 10.1007/s00125-009-1614-2] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
225 Bray GA. Preventing Diabetes: Lessons Learned from the Diabetes Prevention Program and Its Follow-Up. Obesity and Weight Management 2009;5:273-276. [DOI: 10.1089/obe.2009.0603] [Reference Citation Analysis]
226 Unger J, Parkin CG. Appropriate, timely, and rational treatment of type 2 diabetes mellitus: Meeting the challenges of primary care. Insulin 2009;4:144-57. [DOI: 10.1016/s1557-0843(09)80029-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
227 Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009;58:773-95. [PMID: 19336687 DOI: 10.2337/db09-9028] [Cited by in Crossref: 1737] [Cited by in F6Publishing: 1866] [Article Influence: 133.6] [Reference Citation Analysis]
228 Bartnik M, Cosentino F. Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out? Eur Heart J 2009;30:1301-4. [PMID: 19395498 DOI: 10.1093/eurheartj/ehp168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
229 Garber AJ, Handelsman Y, Einhorn D, Bergman DA, Bloomgarden ZT, Fonseca V, Garvey WT, Gavin JR 3rd, Grunberger G, Horton ES, Jellinger PS, Jones KL, Lebovitz H, Levy P, McGuire DK, Moghissi ES, Nesto RW. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008;14:933-946. [PMID: 18996826 DOI: 10.4158/ep.14.7.933] [Cited by in Crossref: 139] [Cited by in F6Publishing: 152] [Article Influence: 10.7] [Reference Citation Analysis]
230 Steele RM, Finucane FM, Simmons RK, Griffin SJ, Wareham NJ, Ekelund U; On behalf of the ProActive research team. Altered respiratory function is associated with increased metabolic risk, independently of adiposity, fitness and physical activity. Diabetic Medicine 2009;26:362-9. [DOI: 10.1111/j.1464-5491.2009.02689.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
231 Gerstein HC. Dysglycemia and cardiovascular risk in the general population. Circulation 2009;119:773-5. [PMID: 19221229 DOI: 10.1161/CIRCULATIONAHA.108.834408] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
232 Zimmet P. Preventing diabetic complications: a primary care perspective. Diabetes Res Clin Pract 2009;84:107-16. [PMID: 19278746 DOI: 10.1016/j.diabres.2009.01.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
233 Steveling A, Völzke H, Nauck M, Wallaschofski H. HbA1c determination – A new diagnostic criterion? 1. LaboratoriumsMedizin 2009;33:-. [DOI: 10.1515/jlm.2009.003et] [Reference Citation Analysis]
234 Steveling A, Völzke H, Nauck M, Wallaschofski H. HbA1c-Bestimmung – ein neues Diagnosekriterium? / HbA1c – The new diagnostic criterion? LaboratoriumsMedizin 2009;33:11-14. [DOI: 10.1515/jlm.2009.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
235 Goldberg R. Guideline-Driven Intervention on SCI-Associated Dyslipidemia, Metabolic Syndrome, and Glucose Intolerance Using Pharmacological Agents. Topics in Spinal Cord Injury Rehabilitation 2009;14:46-57. [DOI: 10.1310/sci1403-46] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
236 Fruchart JC, Sacks FM, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P; Residual Risk Reduction Initiative (R3I). The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. Diab Vasc Dis Res 2008;5:319-35. [PMID: 18958843 DOI: 10.3132/dvdr.2008.046] [Cited by in Crossref: 181] [Cited by in F6Publishing: 241] [Article Influence: 12.9] [Reference Citation Analysis]
237 Sloan FA, Belsky D, Ruiz D Jr, Lee P. Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005. Arch Ophthalmol 2008;126:1548-53. [PMID: 19001223 DOI: 10.1001/archopht.126.11.1548] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
238 Bloomgarden ZT. American College Of Endocrinology Pre-Diabetes Consensus Conference: part one. Diabetes Care. 2008;31:2062-2069. [PMID: 18820229 DOI: 10.2337/dc08-zb10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
239 Fruchart J, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche J, Marx N, Plutzky J, Reiner Ž, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P. The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia. The American Journal of Cardiology 2008;102:1K-34K. [DOI: 10.1016/j.amjcard.2008.10.002] [Cited by in Crossref: 286] [Cited by in F6Publishing: 161] [Article Influence: 20.4] [Reference Citation Analysis]
240 Yang W. Mission: halt diabetes momentum and stop growing epidemic: . Chinese Medical Journal 2008;121:2115-8. [DOI: 10.1097/00029330-200811010-00001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
241 Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. The metabolic syndrome. Endocr Rev. 2008;29:777-822. [PMID: 18971485 DOI: 10.1210/er.2008-0024] [Cited by in Crossref: 1109] [Cited by in F6Publishing: 1194] [Article Influence: 79.2] [Reference Citation Analysis]
242 Gardner TW, Antonetti DA. Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches. Curr Diab Rep 2008;8:263-9. [PMID: 18631437 DOI: 10.1007/s11892-008-0047-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
243 Aroda VR, Ratner R. Approach to the Patient with Prediabetes. The Journal of Clinical Endocrinology & Metabolism 2008;93:3259-65. [DOI: 10.1210/jc.2008-1091] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
244 Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y. Fasting plasma glucose cutoff for diagnosis of diabetes in a Japanese population. J Clin Endocrinol Metab 2008;93:3425-9. [PMID: 18559920 DOI: 10.1210/jc.2007-2819] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
245 Wong TY, Liew G, Tapp RJ, Schmidt MI, Wang JJ, Mitchell P, Klein R, Klein BE, Zimmet P, Shaw J. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008;371:736-43. [PMID: 18313502 DOI: 10.1016/S0140-6736(08)60343-8] [Cited by in Crossref: 157] [Cited by in F6Publishing: 136] [Article Influence: 11.2] [Reference Citation Analysis]
246 Eldin WS, Emara M, Shoker A. Prediabetes: a must to recognise disease state: Prediabetes. International Journal of Clinical Practice 2008;62:642-8. [DOI: 10.1111/j.1742-1241.2008.01705.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
247 Eldin WS, Ragheb A, Klassen J, Shoker A. Evidence for increased risk of prediabetes in the uremic patient. Nephron Clin Pract 2008;108:c47-55. [PMID: 18087172 DOI: 10.1159/000112529] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
248 Wright AD, Dodson PM. Diabetic retinopathy without diabetes. Diabet Med 2007;24:1174; author reply 1174-5. [PMID: 17888141 DOI: 10.1111/j.1464-5491.2007.02269.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
249 Su W, Dai D, Liu H, Na T, Dai Y. UPREGULATED ENDOTHELIN SYSTEM IN DIABETIC VASCULAR DYSFUNCTION AND EARLY RETINOPATHY IS REVERSED BY CPU0213 AND TOTAL TRITERPENE ACIDS FROM FRUCTUS CORNI. Clin Exp Pharmacol Physiol 2007;34:1228-33. [DOI: 10.1111/j.1440-1681.2007.04698.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
250 Nathan DM. Authors? response. Diabetic Med 2007;24:1174-5. [DOI: 10.1111/j.1464-5491.2007.2269_1.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
251 Tikellis G, Wang JJ, Tapp R, Simpson R, Mitchell P, Zimmet PZ, Shaw J, Wong TY. The relationship of retinal vascular calibre to diabetes and retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetologia 2007;50:2263-71. [DOI: 10.1007/s00125-007-0822-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
252 John Wiley & Sons, Ltd. Current literature in diabetes. Diabetes Metab Res Rev 2007;23:i-ix. [DOI: 10.1002/dmrr.773] [Reference Citation Analysis]